Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00680966 · ClinicalTrials.gov registry record · NA
Sequenced vs. Integrated Delivery of Treatment for Adolescent Depression and SUD
A NA study of Depression and Substance Use Disorders, sponsored by Oregon Research Institute.
- Completed
- Registry status
- NA
- Development phase
- 180
- Enrollment target
- 1
- Study location
NCT00680966: Completed NA study of Depression and Substance Use Disorders, sponsored by Oregon Research Institute.
NCT00680966 is a NA study of Depression and Substance Use Disorders that has completed, run by Oregon Research Institute. The registered enrollment target is 180 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (77% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00680966, a NA study of Depression and Substance Use Disorders, has completed, sponsored by Oregon Research Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 180 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine whether it is more effective to treat adolescents, with diagnoses of both depression and substance use disorder, with a treatment addressing the substance use first and then treating the depression or to first treat the depression and then treat the substance use or whether treating both disorders simultaneously is most effective. It is expected that treatment of both disorders at the same time will be the most effective.
Conditions Studied
Interventions
- BEHAVIORAL Adolescent Coping With Depression/Functional Family Therapy
Study Locations (1)
Oregon
- Oregon Research Institute - Eugene
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 180 participants |
| Start Date | 2008-01 |
| Est. Completion | 2013-06 |
| Phase | NA |
What the finished NCT00680966 record still lists
NCT00680966 is an interventional study that assigns participants to a tested intervention. The registered 180 participants enrollment target is mid-sized for trials with a published cap, below the 786-participant average among 679 other Depression trials with a reported enrollment target (77% lower).
The record links to 3 conditions, with Depression appearing as the primary indexed condition, and to 1 intervention - of which Adolescent Coping With Depression/Functional Family Therapy is the first listed.
NCT00680966 reports a single indexed study location in Oregon.
Frequently Asked Questions
What is clinical trial NCT00680966 about?
NCT00680966 is a clinical study titled "Sequenced vs. Integrated Delivery of Treatment for Adolescent Depression and SUD". The purpose of this study is to determine whether it is more effective to treat adolescents, with diagnoses of both depression and substance use disorder, with a treatment addressing the substance use first and then treating the depression or to first treat the depression and then treat the substanc...
What is the current status of trial NCT00680966?
This trial is currently completed. It is a NA study. The enrollment target is 180 participants. The study started on 2008-01. Estimated completion is 2013-06.
What conditions does trial NCT00680966 study?
This clinical trial studies the following conditions: Depression, Substance Use Disorders, Adolescent.
What interventions are being tested in trial NCT00680966?
The interventions under investigation include: Adolescent Coping With Depression/Functional Family Therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT00680966?
This trial is sponsored by Oregon Research Institute, which has 62 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00680966 being conducted?
This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00680966's enrollment target sits among peer trials
180 224th of 679 higher than 452 of 679 other Depression trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Reaching Out to Distressed Medical Residents, Fellows and Faculty
RECRUITING · NA
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
Cold and Heat Investigation to Lower Levels of Depression
RECRUITING · NA
-
Dosing rTMS for Depression Post-SCI
RECRUITING · NA
-
Exploring Virtual Reality Adventure Training Exergaming
RECRUITING · NA
-
Brief Interventions for Coping with Distress
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01558804 · 180 participants
GRoup A StrePtococcus
- NCT02932176 · 180 participants
Machine Learning for Handheld Vascular Studies
- NCT03384563 · 180 participants · Phase 4
Effect of Dexmedetomidine on the Minimum Alveolar Concentration of Sevoflurane
- NCT03423628 · 180 participants · Phase 1
A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia